NDC11 68135002001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 68135-0020-01 | 68135-0020 |
| 68135-0020-1 | 68135-0020 |
| 68135-020-01 | 68135-020 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NAGLAZYME | GALSULFASE | BioMarin Pharmaceutical Inc. | 59341250-deac-ed71-3823-a4f5d64dbd77 | 2024-09-18 | Boxed warning, Warnings, Adverse reactions | 68135-020-01 68135-020 68135002001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.